Vanguard Global Advisers
BVS icon

Vanguard Global Advisers’s Bioventus BVS Stock Holding History

Vanguard Global Advisers’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$945K Buy
100,117
+2,565
+3% +$24.5K ﹤0.01% 1780
2026
Q1 		$891K Buy
+97,552
New +$818K ﹤0.01% 1719

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Global Advisers's BVS Position: Q2 2026 in Review

Vanguard Global Advisers increased its Bioventus (BVS) stake by 2.6% in Q2 2026, buying an estimated $24.5K and bringing the position to 100,117 shares worth $945K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Vanguard Global Advisers first reported a position in BVS in Q1 2026 and has held it in 2 quarters since. 155 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Vanguard Global Advisers held 100,117 shares of Bioventus worth $945K as of Q2 2026.
  • Vanguard Global Advisers bought 2,565 Bioventus shares in Q2 2026, an estimated $24.5K.
  • Bioventus made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1780 holding.
  • Vanguard Global Advisers first reported a position in Bioventus in Q1 2026 and has held it in 2 quarters since.
  • 155 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.